A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig (vascular Communicated by U. S. von Euler, November 8, 1982 ABSTRACT Electrical stimulation of the cervical vagus nerve in anesthetized guinea pigs induced a rapid increase in respiratory insufflation pressure, suggesting increased airway resistance. 
Trp7,9,Leu"]SP inhibited the permeability increase induced by both vagus nerve stimulation and exogenous SP. SP release from vagal sensory nerves was indirectly shown by reduction in the bronchial levels of SP after nerve stimulation in vivo. The data suggest that a major portion of the vagally or capsaicin-induced increase in bronchial smooth muscle tone is caused by SP release from sensory neurons. In addition, activation of vagal SP-containing sensory nerves induces local edema. Tracheobronchial afferent SP-containing C fibers may thus exert local control of smooth muscle tone and vascular permeability in normal and pathophysiological conditions. Activation of sensory neurons leads to local vasodilation (1) and increased vascular permeability in the skin (2) . Both effects are abolished in animals that have been treated with capsaicin (3, 4) , the pungent agent of hot peppers, which causes selective degeneration ofchemosensitive primary afferent neurons when given neonatally (3) . Administration of capsaicin in vitro releases substance P (SP) from unmyelinated sensory nerves (5) and it also causes long-term depletion of SP in these neurons (6) . SP is a strong candidate to mediate neurogenic inflammatory responses and antidromic vasodilation, because it induces increases in vascular permeability (4) and vasodilation (7) . Antidromic trigeminal nerve stimulation has been shown to cause SP release from nerve terminals in the dental pulp (8, 9) and eye (10) . Furthermore, it has been shown that the antidromic vasodilation in the pulp (11) and the inflammation in the eye on IR irradiation (12) can be inhibited by SP antagonists. Recent studies suggest that capsaicin-sensitive sensory nerves of vagal origin can induce neurogenic inflammation and bronchoconstriction in the respiratory tract (13, 14) .
In this paper, we report that the increase in vascular permeability in the respiratory tract and esophagus and the noncholinergic bronchoconstriction induced by vagus stimulation can be blocked by [D-Argl,D-Pro2,D-Trp7,9,Leul]SP (15) , which is a specific SP antagonist (16) .
MATERIALS AND METHODS
Experiments were performed on adult guinea pigs (250-350 g) of both sexes. Respiratory insufflation pressure was recorded in anesthetized guinea pigs (sodium pentobarbital at 40 mg/kg and suxamethon at 1 mg/kg) as an indication of changes in tracheobronchial resistance to air (17) . The respiratory rate was 40/min and the respiration volume was 3 ml per stroke. Heart beat rate and systemic arterial blood pressure were continuously recorded via a catheter in a carotid artery connected to a pressure transducer and a Grass polygraph. Both cervical vagal nerves were cut and the distal ends were stimulated at 10 V, 5 ms, 10 Hz for 30 s. Atropine (0.5 mg/kg), SP, capsaicin, or the SP antagonist ([D-Arg1,D-Pro2,D-Trp79, Leu"]SP) were administered intravenously (i.v.) via ajugular vein catheter. Because of the histamine-releasing properties of the SP antagonist (18) , the animals were first treated with mepyramine at 1 mg/kg and cimetidine at 1 mg/kg. These histamine antagonists did not influence the insufflation pressure or permeability response to SP, capsaicin, or vagus nerve stimulation. The blue extravasation technique. After electrical stimulation of the cervical vagal nerves for 5 min or 5 min after i.v. injection of SP and capsaicin, the animals were perfused with saline via the aorta. The Evans blue content in the tissue was extracted with formamide and quantified fluorimetrically (19) . To study the microscopic localization of the extravasated Evans blue, tissue pieces were immersion fixed in formalin, sectioned in a cryostat, and examined in a fluorescence microscope. Evans blue exhibits a bright red fluorescence when excited at an absorption maximum of -600 nm (19) . For determination of tissue concentrations of SP-like immunoreactivity (referred to below as SP), tissues were extracted by homogenization and boiling for 10 min in 10 vol of 1.0 M acetic acid. Then, the extracts were centrifuged and lyophilized, and SP was determined by using a highly specific radioimmunoassay (20, 21) . The SP immunoreactivity was characterized by gel chromatography on a Sephadex G-25 column. RESULTS I.v. injection of SP (2 nmol/kg) or capsaicin (10 nmol/kg) induced an increase in respiratory insufflation pressure, as well as vascular changes as evidenced by a decrease in blood pressure ( Fig. 1) . A marked increase in insufflation pressure was also induced by vagus nerve stimulation ( Figs. 1 and 2 ). The decrease in blood pressure and changes in heart rate after SP, capsaicin, or vagal stimulation were not reduced by the SP antagonist (Fig. 1) .
The concentrations of SP in the trachea and stem bronchi from control guinea pigs were 3.17 ± 0.51 and 7.35 ± 0.54 pmol/g (wet weight) of tissue (mean ± SEM; n = 4 or 5), respectively. After 5 min of bilateral vagal stimulation, the corresponding SP levels were 2.23 ± 0.32 and 3.24 ± 0.59 pmol/g (wet weight) of tissue (n = 5). The reduction in SP level of the stem bronchi was 56% (P < 0.01; Student's t test), suggesting a nervous SP release during vagal stimulation. The total amount of SP extracted from the stem bronchi was also reduced after vagal stimulation (P < 0.05), thus excluding the possibility that the effect on the SP level was due to solely an increase in tissue weight caused by local edema. Gel permeation chromatography of an extract of guinea pig trachea showed that the immunoreactive material detected by the assay to a major extent (>90%) eluted at the position of synthetic bovine SP (data not shown).
Electrical field stimulation of isolated tissues from the respiratory tract showed different responses in the various regions (Fig. 3) (22) . Thus, in the trachea, an atropine-sensitive contraction was followed by a long-lasting noncholinergic relaxa- (Fig. 3) . The main bronchus responded by an initial atropine sensitive contraction that was followed by a long-lasting atropine-resistant increase in bronchial tone. The SP antagonist did not reduce the atropine-sensitive portion of the contraction in the main bronchus but almost completely blocked the atropine-resistant contraction (Fig. 3) . After 1 hr of repeated washing, the contractile response gradually returned to control value. The hilus bronchus usually responded to field stimulation with a long-lasting atropine-resistant contraction (Fig. 3) effects of SP and capsaicin were significantly reduced by the SP antagonist (Fig. 2) . Vagus nerve stimulation for 5 min or i.v. injection of SP or capsaicin increased the Evans blue content in tracheal and esophageal tissue, suggesting increased vascular permeability. Fluorescence microscopy of tissue sections showed that red fluorescence due to Evans blue leakage occurred in the subepithelial layer of the respiratory tract from the tracheal level down to bronchioli of the lung (Fig. 4 A and B) . In the esophagus, the Evans blue extravasation was most prominent under the lining epithelium (Fig. 4 D and E 2). This effect of the SP antagonist was also seen in the fluorescence microscope as a lack of red fluorescence in the tissue of the trachea (Fig. 4C ), main and hilus bronchi, bronchioli, and esophagus (Fig. 4F ). Previous treatment with mepyramine and cimetidine did not inhibit the extravasation after SP, capsaicin, or vagus nerve stimulation (data not shown).
DISCUSSION
The present data show that a SP antagonist, [D-Arg',D-Pro2,DTrp7'9,Leu11]SP, markedly reduced the vagally or capsaicin-induced increase in bronchial smooth muscle tone, as well as the increased extravasation of Evans blue in the respiratory tract and esophagus after vagus nerve stimulation. This suggests that antidromic or local activation of sensory neurons of vagal origin induces a local release of SP, causing bronchoconstriction and local edema in the respiratory tract (13) . The usefulness of the SP antagonist was enhanced by the finding that virtually all of its stimulatory effects were blocked by histamine antagonists. The SP-immunoreactive nerves in the trachea, stem bronchi (17), and esophagus are capsaicin sensitive and originate mainly from vagal sensory ganglia (23) . The occurrence of a noncholinergic excitatory component in the regulation of bronchial smooth muscle tone has recently been demonstrated both in vitro (22) and in vivo (14) . This component, which occurs mainly in the distal bronchial tree (22) , is characterized by a long-lasting contraction. Recent observations indicate that this type of contraction is absent in animals previously treated with capsaicin (14) .
In vivo experiments with capsaicin-treated animals (14) and the present data from experiments using the SP antagonist suggest that SP release from sensory nerves causes most of the vagally induced increase in insufflation pressure. Sensory SP nerves also exist in the tracheal smooth muscle, although no certain reduction of the contractile response in the trachea to field stimulation was observed in capsaicin-treated animals (14) or after incubation with the SP antagonist. Furthermore, capsaicin also contracts the trachea. The present data suggest that this contraction is due to SP release from sensory nerves. This is in agreement with the effects of capsaicin on the central branch of sensory nerves (5) . The simultaneous presence of the strong dilatory component in the trachea may, however, mask the effects of SP release from local sensory nerves. Earlier data from capsaicin-treated animals indicate an interaction between acetylcholine and SP neurons in vivo (14) . This result is supported by the finding that the vagally induced insufflation-pressure response was reduced by 78% after administration of the SP antagonist although the atropine-resistant component has been found to be about 40% (14) .
The selectivity of the SP antagonist was substantiated by several observations. The vagally induced decrease in blood pressure or bradycardia was unaffected. Furthermore, the vascular effects of SP and capsaicin were virtually unchanged, confirming previous findings that the decrease in blood pressure induced by SP is much more resistant to SP antagonists than is that of smooth muscle contractions (24) . This may be explained by the existence of different types of SP receptors (16, 24) . The specificity of the SP antagonist was also supported by the observation that the atropine-sensitive contractions and atropineresistant relaxations in vitro were not blocked by [D-Arg',DPro2,D-Trp7'9,Leun']SP. Vagally induced neurogenic inflammation has been described in the rat respiratory tract (13, 25) . Also, this reaction was absent in capsaicin-treated animals, which, together with the present data from experiments using the SP antagonist, indicates that SP is mediating this response. Many capsaicin-sensitive SP nerves are also present where the Evans Neurobiology: Lundberg et al.
blue leakage was most pronounced-i. e., close to the lining respiratory epithelium (17) . In contrast to observations from the skin (4), the effect of SP on permeability in the lung and esophagus did not seem to be indirect via histamine release.
Capsaicin-sensitive SP nerves are generally believed to belong to the C-fiber group and have characteristics of chemosensitive nociceptive neurons (3, 6) . Vagal afferent C fibers are present in the respiratory tract (26) . These C fibers appear to have little influence on the normal control of breathing (26) 
